Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Interest & Investment Income: 2014-2024

Historic Interest & Investment Income for vTv Therapeutics (VTVT) over the last 11 years, with Dec 2024 value amounting to $1.6 million.

  • vTv Therapeutics' Interest & Investment Income fell 20.83% to $399,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 17.16%. This contributed to the annual value of $1.6 million for FY2024, which is 231.57% up from last year.
  • Per vTv Therapeutics' latest filing, its Interest & Investment Income stood at $1.6 million for FY2024, which was up 231.57% from $472,000 recorded in FY2023.
  • vTv Therapeutics' Interest & Investment Income's 5-year high stood at $1.6 million during FY2024, with a 5-year trough of $1,000 in FY2021.
  • In the last 3 years, vTv Therapeutics' Interest & Investment Income had a median value of $472,000 in 2023 and averaged $796,333.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 91.67% in 2021, then spiked by 35,100.00% in 2022.
  • Over the past 5 years, vTv Therapeutics' Interest & Investment Income (Yearly) stood at $12,000 in 2020, then tumbled by 91.67% to $1,000 in 2021, then spiked by 35,100.00% to $352,000 in 2022, then soared by 34.09% to $472,000 in 2023, then skyrocketed by 231.57% to $1.6 million in 2024.